News
JAMA Neurology publishes landmark study showing neuropacs™ AI technology significantly enhances the diagnostic accuracy of Parkinson’s disease and atypical parkinsonism
NIH-funded clinical trial accelerates the launch of innovative software for Parkinson’s Disease diagnostic.
Neuropacs Appoints Dr. David R. Nelson to its Board of Advisors
Company secures a visionary health affairs leader for the launch of their innovative Parkinson’s diagnosis software.
Automated Imaging Diagnostics Awarded Phase II Grant for Clinical Performance Testing of neuropacs™ in Parkinsonism Diagnosis
Revolutionary Alzheimer’s Diagnostic Technology Option Agreement Secured by neuropacs in Collaboration with UF
Ready to improve your outcomes using our precision AI platform?
Our dedicated team can help you determine which neuropacs™ solution best fits your clinical or research needs.